Wednesday, June 10, 2026

pharma · Generalized Pustular Psoriasis · Schizophrenia · VNDA

Vanda Pharmaceuticals Netherlands

NovaPharmaNews editorial coverage mentioning Vanda Pharmaceuticals Netherlands — regulatory, clinical, and market analysis.

2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037, US HQ
2003 Founded
600 Employees
Public company Type
VNDA · NYSE Ticker
Company details
Status
Public
HQ
2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037, US
Founded
2003
Employees
600
Programs
60
Drugs
19
Patents
96
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Vanda Pharmaceuticals Netherlands — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Vanda Pharmaceuticals Netherlands — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning Vanda Pharmaceuticals Netherlands yet.

Back to company overview →